Antioxidants are substances that can prevent or slow damage to cells caused by free radicals, unstable molecules that the body produces as a reaction to environmental and other pressures. Free radicals may play a role in heart disease, cancer and other diseases. If the body cannot process and remove free radicals efficiently, oxidative stress can result. This can harm cells and body function. Free radicals are also known as reactive oxygen species (ROS). In this research, Triptorelin® (TRP) conjugates of triphenylmethanol derivatives (TPMs) were synthesized to evaluate their in vitro lipid peroxidation potency. Comparative lipid peroxidation assays between TRP-TPMs conjugates and the corresponding TPMs derivatives were measured using thiobarbituric reactive substance (TBARS) in a dose- and time-dependent manner following the Fenton’s pathway. Overall, TBARS decreased between 20% - 30% for the treated samples of synthesized conjugates compared to their respective control physical mixtures. These data suggest that TRP-TPMs derivatives can be used to improve the biological activity of TRP.
References
[1]
Thurston, B.R. (2006) Chemistry and Pharmacology of Anticancer Drugs. CRC Press, Boca Raton, 139-151.
[2]
Leonard, G.G. (2009) Effective Testosterone Suppression for Prostate Cancer: Is There a Best Castration Therapy? Reviews in Urology, 11, 52-60.
[3]
Yang, X., Deng, W., Fu, L., Blanco, E., Gao, J., Quan, D. and Shuai, X. (2008) Folate Functionalized Polymeric Micelles for Tumor Targeted Delivery of a Potent Multidrug-Resistance Modulator FG020326. Journal of Biomedical Materials Research Part A, 86, 48-60. https://doi.org/10.1002/jbm.a.31537
[4]
Chavanpatil, M.D., Khdair, A., Gerard, B., Bachmeier, C., Miller, D.W., Shekhar, M.P.V. and Panvam, J. (2007) Surfactant-Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux. Molecular Pharmacology, 4, 730-738.
https://doi.org/10.1021/mp070024d
[5]
Sadava, D., Coleman, A. and Kane, S.E. (2002) Liposomal Daunorubicin Overcomes Drug Resistance in Human Breast, Ovarian and Lung Carcinoma Cells. Journal of Liposome Research, 12, 301-309. https://doi.org/10.1081/LPR-120016196
[6]
Ibsen, S., Zahavy, E., Wrasdilo, W., Berns, M., Chan, M. and Esener, S. (2010) A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy. Pharmaceutical Research, 27, 1848-1860.
https://doi.org/10.1007/s11095-010-0183-x
[7]
Chhikara, B.S. and Parang, K. (2010) Development of Cytarabine Prodrugs and Delivery Systems for Leukemia Treatment. Expert Opinion on Drug Delivery, 7, 1399-1414. https://doi.org/10.1517/17425247.2010.527330
[8]
Kratz, F. (2007) DOXO-EMCH (INNO-206): The First Albumin Binding Prodrug of Doxorubicin to Enter Clinical Trials. Expert Opinion on Investigational Drugs, 16, 855-866. https://doi.org/10.1517/13543784.16.6.855
[9]
Wang, Y., Li, L., Jiang, W., Yang, Z. and Zhang, Z. (2006) Synthesis and Preliminary Antitumor Activity Evaluation of a DHA and Doxorubicin Conjugate. Bioorganic & Medicinal Chemistry Letters, 16, 2974-2977.
https://doi.org/10.1016/j.bmcl.2006.02.066
[10]
Kumar, S.A., Peter, Y.A. and Nadeau, J.L. (2008) Facile Biosynthesis, Separation and Conjugation of Gold Nanoparticles to Doxorubicin. Nanotechnology, 19, 495-501.
https://doi.org/10.1088/0957-4484/19/49/495101
[11]
You, J., Zhang, G. and Li, C. (2010) Exceptionally High Payload of Doxorubicin in Hollow Gold Nanosphere for Near-Infrared Light Triggered Drug Release. ACS Nano, 4, 1033-1041. https://doi.org/10.1021/nn901181c
[12]
Massing, U. and Fuxius, S. (2000) Liposomal Formulations of Anticancer Agents: Selectivity and Effectiveness. Drug Resistance Updates, 3, 171-177.
https://doi.org/10.1054/drup.2000.0138
[13]
Derossi, D., Joliot, A.H., Chassaing, G. and Prochiantz, A. (1994) The Third Helix of the Antennapedia Homeodomain Translocates through Biological Membranes. The Journal of Biological Chemistry, 269, 10444-10450.
[14]
Derossi, D., Chassaing, G. and Prochiantz, A. (1998) Trojan Peptides: The Penetratin System for Intracellular Delivery. Trends in Cell Biology, 8, 84-87.
https://doi.org/10.1016/S0962-8924(98)80017-2
[15]
Meyer-Losic, F., Quinonero, J., Dubois, V., Alluis, B., Dechambre, M., Michel, M., Cailler, F., Fernandez, A.M., Trouet, A. and Kearsey, J. (2006) Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell). Journal of Medicinal Chemistry, 49, 6908-6916.
https://doi.org/10.1021/jm0606591
[16]
Che, C., Yang, G., Thiot, C., Lacoste, M.-C., Currie, J.-C., Demeule, M., Regina, A., Beliveau, R. and Castaigne, J.-P. (2010) New Angiopep Modified Doxorubicin (ANG1007) and Etoposide (ANG1009) Chemotherapeutics with Increased Brain Penetration. Journal of Medicinal Chemistry, 53, 2814-2824.
https://doi.org/10.1021/jm9016637
[17]
Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiriksdottir, E., Jiang, Y., Sassian, M., Ostlund, P., Hallbrink, M. and Langel, U. (2006) Overcoming Methotrexate Resistance in Breast Cancer Tumour Cells by the Use of a New Cell-Penetrating Peptide. Biochemical Pharmacology, 71, 416-425. https://doi.org/10.1016/j.bcp.2005.10.048
[18]
Amir, N.S., Rakesh, T., Bhupender, S.C., Dindyal, M. and Keykavous, P. (2013) Design and Biological Evaluation of Cell-Penetrating Peptide-Doxorubicin Conjugates as Prodrugs. Molecular Pharmaceutics, 10, 488-499.
https://doi.org/10.1021/mp3004034
[19]
Zhu, S., Hong, M., Zhang, L., Tang, G., Jiang, Y. and Pei, Y. (2010) PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and in Vivo Tumor Accumulation. Pharmaceutical Research, 27, 161-174.
https://doi.org/10.1007/s11095-009-9992-1
[20]
Scalbert, A., Manach, C., Morand, C. and Remesy, C. (2005) Dietary Polyphenols and the Prevention of Diseases. Critical Reviews in Food Science and Nutrition, 45, 287-306. https://doi.org/10.1080/1040869059096
[21]
Spencer, J.P., Abd El Mohsen, M.M., Minihane, A.M. and Mathers, J.C. (2008) Biomarkers of the Intake of Dietary Polyphenols: Strengths, Limitations and Application in Nutrition Research. British Journal of Nutrition, 99, 12-22.
https://doi.org/10.1017/S0007114507798938
[22]
Bhooshan, P.K. and Rizv, S.I. (2009) Plant Polyphenols as Dietary Antioxidants in Human Health and Disease. Oxidative Medicine and Cellular Longevity, 2, 270-278.
https://doi.org/10.4161/oxim.2.5.9498
[23]
Yang, C.S., Landau, J.M., Huang, M.T. and Newmark, H.L. (2001) Inhibition of Carcinogenesis by Dietary Polyphenolic Compounds. Annual Review of Nutrition, 21, 381-406. https://doi.org/10.1146/annurev.nutr.21.1.381
[24]
Johnson, I.T., Williamson, G. and Musk, S.R.R. (1994) Anticarcinogenic Factors in Plant Foods: A New Class of Nutrients? Nutrition Research Reviews, 7, 175-204.
https://doi.org/10.1079/NRR19940011
[25]
Talalay, P., De Long, M.J. and Prochaska, H.J. (1988) Identification of a Common Chemical Signal Regulating the Induction of Enzymes That Protect against Chemical Carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 85, 8261-8265. https://doi.org/10.1073/pnas.85.21.8261
[26]
Khan, N. and Mukhtar, H. (2008) Multitargeted Therapy of Cancer by Green Tea Polyphenols. Cancer Letters, 269, 269-280.
https://doi.org/10.1016/j.canlet.2008.04.014
[27]
Suja, S., Bharat Raj, B., Kyung Ja, C., Keun-Hyeung, L. and Hyeongjin, C. (2007) Methylenedisalicylic Acid Derivatives: New PTP1B Inhibitors That Confer Resistance to Diet-Induced Obesity. Bioorganic & Medicinal Chemistry Letters, 17, 2760-2764. https://doi.org/10.1016/j.bmcl.2007.02.069
[28]
Mark, C., Suseela Erik, D.C., Dominique, S., Mark, E.G. and Julie, A.B. (1991) Synthesis and Anti-HIV Activities of Low Molecular Weight Aurintricarboxylic Acid Fragments and Related Compounds. Journal of Medicinal Chemistry, 34, 337-342.
https://doi.org/10.1021/jm00105a053
[29]
Gutteridge, J.M. and Halliwell, B. (1990) The Measurement and Mechanism of Lipid Peroxidation in Biological Systems. Trends in Biochemical Sciences, 15, 129-135. https://doi.org/10.1016/0968-0004(90)90206-Q
[30]
Requena, J.R., et al. (1997) Quantification of Malondialdehyde and 4-Hydroxynonenal Adducts to Lysine Residues in Native and Oxidized Human Low-Density Lipoprotein. Biochemical Journal, 322, 317-325. https://doi.org/10.1042/bj3220317
[31]
Janero, D.R. (1990) Malondialdehyde and Thiobarbituric Acid-Reactivity as Diagnostic Indices of Lipid Peroxidation and Peroxidative Tissue Injury. Free Radical Biology & Medicine, 9, 515-540. https://doi.org/10.1016/0891-5849(90)90131-2
[32]
Gasparovic, A.C., et al. (2013) Assays for the Measurement of Lipid Peroxidation. Methods in Molecular Biology, 965, 283-296.
https://doi.org/10.1007/978-1-62703-239-1_19
